Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
VALENCIA, Calif., Feb. 16, 2016 -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, announced today that it will present at the RBC Capital Markets 2016 Healthcare Conference on Tuesday, February 23, 2016 at 10:00 AM (ET) at The Palace Hotel, in New York, NY.
Presenting from the Company will be its Chief Executive Officer, Matthew Pfeffer.
Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
Company Contact: Matthew J. Pfeffer Chief Executive Officer (661) 775-5300 [email protected]
